IMPACT OF DECOMPRESSIVE CRANIOTOMY ON OUTCOME OF SPONTANEOUS INTRACRANIAL HEMORRHAGE
Main Article Content
Keywords
Abstract
Introduction: The effectiveness of decompressive craniotomy in the spontaneous intracranial hemorrhage (ICH) has always provoked question and concerns within the medical field especially from neurosurgeons and critical care physicians.
Objective: The main objective of the study is to find the impact of decompressive craniotomy on outcome of spontaneous intracranial hemorrhage.
Methodology: This prospective observational study was conducted at PIMS, Islamabad during July 2023 to June 2024. Data were collected from 110 patients who were diagnosed with spontaneous ICH and underwent decompressive craniotomy. At the time of admission all the patients were evaluated by performing a detailed neurological examination and undergoing preliminary imaging procedures. Results: The study included 110 patients with a mean age of 52.5 ± 12.4 years, ranging from 35 to 65 years. The majority of patients were male (61.8%), with 40.9% having hypertension, 27.3% with diabetes, and 13.6% with a history of previous stroke. The initial Glasgow Coma Scale (GCS) score was 8.2 ± 3.5, with over half of the patients (54.5%) presenting with a GCS score of 8 or less, indicating severe neurological impairment. Mean timing of surgery was 6.8 ± 2.3 hours after symptom onset, with an average surgery duration of 3.2 ± 1.1 hours. The mean size of the bone flap removed was 12.5 ± 2.4 cm.
Conclusion: It is concluded that decompressive craniotomy can significantly reduce mortality in patients with severe spontaneous intracranial hemorrhage, particularly in those with large hematomas and midline shifts.
References
2. Moussa WM, Khedr W. Decompressive craniectomy and expansive duraplasty with evacuation of hypertensive intracerebral hematoma, a randomized controlled trial. Neurosurg Rev. 2017;40:115–127.
3. Weimar C, Kleine-Borgmann J. Epidemiology, prognosis and prevention of non-traumatic intracerebral hemorrhage. Curr Pharm Des. 2017;23:2193–2196.
4. Cai Q, Zhang H, Zhao D, et al. Analysis of three surgical treatments for spontaneous supratentorial intracerebral hemorrhage. Medicine (Baltimore) 2017;96
5. Lo YT, See AAQ, King NKK. Decompressive craniectomy in spontaneous intracerebral hemorrhage: a case-control study. World Neurosurg. 2017;103:815–820.e812
6. Yuan JH, Chen SH, Fu SS, et al. Analysis on the gender-specific risk factors of new-onset cerebral hemorrhage. Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46:725–731.
7. Keep RF, Andjelkovic AV, Xiang J, et al. Brain endothelial cell junctions after cerebral hemorrhage: changes, mechanisms and therapeutic targets. J Cereb Blood Flow Metab. 2018;38:1255–1275.
8. Xu X, Chen X, Li F, et al. Effectiveness of endoscopic surgery for supratentorial hypertensive intracerebral hemorrhage: a comparison with craniotomy. J Neurosurg. 2018;128:553–559.
9. Tang Y, Yin F, Fu D, et al. Efficacy and safety of minimal invasive surgery treatment in hypertensive intracerebral hemorrhage: a systematic review and meta-analysis. BMC Neurol. 2018;18:136.
10. Yao Z, Ma L, You C, He M. Decompressive craniectomy for spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg. 2018;110:121–128.
11. Hou Z, Tian R, Han F, et al. Decompressive craniectomy protects against hippocampal edema and behavioral deficits at an early stage of a moderately controlled cortical impact brain injury model in adult male rats. Behav Brain Res. 2018;345:1–8.
12. Shahid AH, Mohanty M, Singla N, et al. The effect of cranioplasty following decompressive craniectomy on cerebral blood perfusion, neurological, and cognitive outcome. J Neurosurg. 2018;128:229–235.
13. Cusack TJ, Carhuapoma JR, Ziai WC. Update on the treatment of spontaneous intraparenchymal hemorrhage: medical and interventional management. Curr Treat Options Neurol. 2018;20:1.
14. Sahuquillo J, Dennis JA. Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury. Cochrane Database Syst Rev. 2019;12
15. Yamal JM, Hannay HJ, Gopinath S, et al. Glasgow outcome scale measures and impact on analysis and results of a randomized clinical trial of severe traumatic brain injury. J Neurotrauma. 2019;36:2484–2492.
16. Purrucker JC, Steiner T. Atypical intracerebral hemorrhage-etiology and acute management. Nervenarzt. 2019;90:423–441.
17. Gross BA, Jankowitz BT, Friedlander RM. Cerebral intraparenchymal hemorrhage: a review. JAMA. 2019;321:1295–1303.
18. Xu S, Du B, Shan A, et al. The risk factors for the postoperative pulmonary infection in patients with hypertensive cerebral hemorrhage: a retrospective analysis. Medicine (Baltimore) 2020;99
19. Mao Y, Shen Z, Zhu H, et al. Observation on therapeutic effect of stereotactic soft channel puncture and drainage on hypertensive cerebral hemorrhage. Ann Palliat Med. 2020;9:339–345.
20. Wang X, Chen Y, Wang Z, Qian M. Clinical research of early hyperbaric oxygen therapy on patients with hypertensive cerebral hemorrhage after craniotomy. Turk Neurosurg. 2020;30:361–365.
21. Kim BJ, Kwon SU, Park JH, et al. Cilostazol versus aspirin in ischemic stroke patients with high-risk cerebral hemorrhage: subgroup analysis of the PICASSO trial. Stroke. 2020;51:931–937.